![2-Piperazinone,1-[3-(trifluoromethoxy)phenyl]-](https://static.cymitquimica.com/cas-image/60331-2-piperazinone-1-3-trifluoromethoxy-phenyl.png)
CAS: 215649-79-9 - 2-Piperazinone,1-[3-(trifluoromethoxy)phenyl]-
Formula:C11H11F3N2O2
- Synonyms:
- Piperazinone,1-[3-(trifluoromethoxy)phenyl]- (9CI)
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one REF: IN-DA007PX8CAS: 215649-79-9 | - - - | To inquire | Thu 21 Nov 24 |
 | 1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one hydrochloride REF: 3D-FT51367CAS: 215649-79-9 | Min. 95% | To inquire | Thu 02 Jan 25 |
 | 1-(3-(TRIFLUOROMETHOXY)PHENYL) PIPERAZIN-2-ONE HCL REF: 10-F333973CAS: 215649-79-9 | 95.0% | - - - | Discontinued product |
| 1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one REF: 10-F604515CAS: 215649-79-9 | 95+% | - - - | Discontinued product |
1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one
CAS:215649-79-9
Formula:
C11H12ClF3N2O2
Molecular weight:
296.6734
Ref: IN-DA007PX8
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 21 Nov 2024
1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one hydrochloride
CAS:215649-79-9
Please enquire for more information about 1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one hydrochloride including the price, delivery time and more …
Formula:
C11H11F3N2O2·HCl
Purity:
Min. 95%
Molecular weight:
296.67 g/mol
Ref: 3D-FT51367
| 1g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
1-(3-(TRIFLUOROMETHOXY)PHENYL) PIPERAZIN-2-ONE HCL
CAS:215649-79-9
Purity:
95.0%
Molecular weight:
296.6700134277344
Ref: 10-F333973
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
1-(3-(Trifluoromethoxy)phenyl)piperazin-2-one
CAS:215649-79-9
Purity:
95+%
Molecular weight:
260.21600341796875
Ref: 10-F604515
| 1g | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
